Corsair Pharma is developing transformative solutions to improve the therapeutic profile of medications and provide superior treatment options for patients. The company is focused on the development of novel prodrugs of treprostinil to treat patients with PAH using a once-daily transdermal patch.
Company Details
- Employees
- 12
- Address
- 1230 Bordeaux Dr, Sunnyvale,california 94089,united States
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://www.corsairpharma.com
- HQ
- Sunnyvale, California
Corsair Pharma Questions
Corsair Pharma's website is http://www.corsairpharma.com
Corsair Pharma's LinkedIn profile is https://www.linkedin.com/company/corsairpharma
Corsair Pharma has
12 employees.
View email and phone details for 12
employees at Corsair Pharma.
Corsair Pharma's industry is
Pharmaceutical Manufacturing
Corsair Pharma's top competitors are
Theranica,
Junson Capital,
Butterfly Medical,
New Rhein Healthcare Investors,
百明信康生物技术（杭州）有限公司 Worgpharma,
Accuragen,
Neuraptive Therapeutics, Inc.,
Scienture Llc,
Wallabyphenox,
Allotex.
Corsair Pharma's categories are Pharmaceutical Manufacturing
